Loading ...
Sorry, an error occurred while loading the content.

Placebos Fight Depression As Well As Drugs

Expand Messages
  • NHNE
    NHNE News List Current Members: 732 Subscribe/unsubscribe/archive info at the bottom of this message. Spring/Summer Fundraiser: Money needed = $916.00
    Message 1 of 1 , May 8, 2002
      NHNE News List
      Current Members: 732
      Subscribe/unsubscribe/archive info at the bottom of this message.

      Spring/Summer Fundraiser:
      Money needed = $916.00
      Donations to date = $395.00
      Number of people who have helped = 5
      Funds still needed = $521.00
      To make a tax-deductible donation:
      Web: http://www.nhne.com/main/donations.html
      eMail: nhne@...
      Phone: (928) 282-6120
      Fax: (815) 346-1492
      Mail: NHNE, P.O. Box 2242, Sedona, AZ 86339
      Credit Cards: Please include number, expiration date, phone number.
      Thank you!


      By Shankar Vedantam
      Washington Post
      Tuesday, May 7, 2002; Page A01


      After thousands of studies, hundreds of millions of prescriptions and tens
      of billions of dollars in sales, two things are certain about pills that
      treat depression: Antidepressants like Prozac, Paxil and Zoloft work. And so
      do sugar pills.

      A new analysis has found that in the majority of trials conducted by drug
      companies in recent decades, sugar pills have done as well as -- or better
      than -- antidepressants. Companies have had to conduct numerous trials to
      get two that show a positive result, which is the Food and Drug
      Administration's minimum for approval.

      What's more, the sugar pills, or placebos, cause profound changes in the
      same areas of the brain affected by the medicines, according to research
      published last week. One researcher has ruefully concluded that a higher
      percentage of depressed patients get better on placebos today than 20 years

      Placebos -- or dud pills -- have long been used to help scientists separate
      the "real" effectiveness of medicines from the "illusory" feelings of
      patients. The placebo effect -- the phenomenon of patients feeling better
      after they've been treated with dud pills -- is seen throughout the field of
      medicine. But new research suggests that the placebo may play an
      extraordinary role in the treatment of depression -- where how people feel
      spells the difference between sickness and health.

      The new research may shed light on findings such as those from a trial last
      month that compared the herbal remedy St. John's wort against Zoloft. St.
      John's wort fully cured 24 percent of the depressed people who received it,
      and Zoloft cured 25 percent -- but the placebo fully cured 32 percent.

      The confounding and controversial findings do not mean that antidepressants
      do not work. But clinicians and researchers say the results do suggest that
      Americans may be overestimating the power of the drugs, and that the
      medicines' greatest benefits may come from the care and concern shown to
      patients during a clinical trial -- a context that does not exist for
      millions of patients using the drugs in the real world.

      "The drugs work, and I prescribe them, but they are not what they are
      cracked up to be," said Wayne Blackmon, a Washington psychiatrist whose
      practice largely comprises patients who suffer from depression. "I know from
      clinical experience the drugs alone don't do the job."

      Still, drugs may have become the reflexive treatment for the vast majority
      of Americans receiving medical attention for depression: As the number of
      doctor visits for depression rose from 14 million in 1987 to almost 25
      million last year, medications were prescribed for nine in 10 patients,
      according to research published last week.

      It is not clear how many patients received medicines in a context of
      therapy, although research has indicated that combining medicines with
      psychotherapy produces the best results.

      But Randall Stafford, the Stanford University physician who conducted the
      study on doctor visits, found that less than one-third of them in 2001 were
      to psychiatrists and two-thirds of them were to primary care physicians. The
      former are more likely to situate the medicines in a larger context of
      therapy, while the latter are less knowledgeable about therapy, more pressed
      for time and less likely to offer patients anything like the attention they
      would receive in a clinical trial.

      The average participant in an eight-week trial spends about 20 hours being
      examined by top experts and highly trained caregivers, said Seattle
      psychiatrist Arif Khan, who studied the placebo effect in trials submitted
      to the FDA. Participants -- including those being given sugar pills -- are
      asked detailed questions about how they are feeling, and their every
      psychological change is closely noted.

      In comparison, Khan noted, the average patient with depression sees a doctor
      perhaps 20 minutes a month.

      His analysis of 96 antidepressant trials between 1979 and 1996 showed that
      in 52 percent of them, the effect of the antidepressant could not be
      distinguished from that of the placebo. Khan said the makers of Prozac had
      to run five trials to obtain two that were positive, and the makers of Paxil
      and Zoloft had to run even more. He analyzed trials that were made public in
      the medical literature, which tend to show positive results, and those that
      were not.

      "It speaks to the difficulty we have in classifying and identifying the
      disorders we deal with," said Thomas Laughren, who heads the group of
      scientists at the FDA that evaluates the medicines. "Psychiatric diagnosis
      is descriptive. We don't really understand psychiatric disorders at a
      biological level."

      Patients with similar symptoms, he explained, may have different problems
      with their brain chemistry. Scientists don't understand the neural
      mechanisms of depression -- or why medicines like Prozac and Paxil work.

      "We like to think we give people treatments and they get better," said
      Andrew Leuchter, a professor of psychiatry at UCLA. "We have this fallacy of
      success, but we don't know in any individual why they get better.
      Undoubtedly one of those factors is the time we spend with people and the
      connectedness that gives patients."

      In January, Leuchter published a study in the American Journal of
      Psychiatry, in which he tracked some of the brain changes associated with
      drugs such as Prozac and Effexor, which are called selective serotonin
      reuptake inhibitors. When Leuchter compared the brain changes in patients on
      placebos, he was amazed to find that many of them had changes in the same
      parts of the brain that are thought to control important facets of mood.

      Patients who got better on placebos showed heightened activity in the
      prefrontal lobe, and that activity continued to rise during the eight weeks
      of the study. Those who responded to medicine initially showed a decline in
      prefrontal brain activity, then a rise that eventually tapered off.
      Thirty-eight percent of patients responded to the placebo, and 52 percent to
      the medicines.

      Once the trial was over and the patients who had been given placebos were
      told as much, they quickly deteriorated. People's belief in the power of
      antidepressants may explain why they do well on placebos. Patients in trials
      are not told which they are receiving.

      Likewise, sea changes in the treatment of depression -- including the
      reduction in the stigma attached to mental illness, the widespread use of
      antidepressants and the immense marketing efforts by their manufacturers --
      may explain why Timothy Walsh, a psychiatrist at Columbia University,
      recently found that the placebo effect has grown in recent years. He found
      that greater percentages of people tended to get better on placebos during
      trials of antidepressants in 2000 than in 1981.

      Some observers assert that the medicines themselves work because of the
      placebo effect, but most psychiatrists believe the drugs do have an effect
      of their own. Drugs are a "placebo-plus" treatment, said Helen Mayberg, head
      of neuropsychiatry at the Rotman Research Institute at the University of

      In a study published last week in the American Journal of Psychiatry,
      Mayberg evaluated brain changes during trials using a sophisticated brain
      imaging technique. She found that medicines, besides working on areas that
      are activated by placebos, also work on areas deep in the brain stem, the
      hippocampus and striatum.

      Since both depression and the effect of the medicines are still not well
      understood, it's not clear what these changes mean. While they could be
      irrelevant effects, Mayberg said a better explanation is that the drugs
      affect areas deep within the brain and then work upward to affect parts of
      the brain that control mood. Placebos may work in the reverse direction. In
      part, this may explain why drug effects tend to be more reliable than
      placebos in the long run.

      Mayberg likened depression to a room with a hole in one window.

      "You are trying to set a thermostat -- it's 100 degrees outside and you want
      it to be 70," she said. "If you set the thermostat to 70, that doesn't work.
      But if I set my thermostat to 50, that fools the system and gets the
      temperature back to 70."

      Both drugs and placebos -- chemicals and beliefs -- may impose different
      chemical pressures on the brain that reset the "temperature." The real
      problem, of course, is that no one knows how to fix the hole in the window,
      or even where exactly it is. "This is a thousand-piece puzzle with no
      picture on the box," sighed Mayberg.

      Blackmon, the Washington psychiatrist, said it behooved mental health
      clinicians to better integrate the power of biological treatments with the
      effects of belief and therapy.

      "We would say it's absurd if an internist says, 'I believe in penicillin, so
      everyone should get penicillin whether they have cancer or a broken bone,"
      he said.






      NHNE News List:

      To subscribe, send a message to:

      To unsubscribe, send a message to:

      To review current posts:

      Published by NewHeavenNewEarth (NHNE)
      eMail: nhne@...
      NHNE Website: http://www.nhne.com/
      Phone: (928) 282-6120
      Fax: (815) 346-1492

      Appreciate what we are doing?
      You can say so with a tax-deductible donation:

      P.O. Box 2242
      Sedona, AZ 86339
    Your message has been successfully submitted and would be delivered to recipients shortly.